GW117: A novel serotonin (5-HT2C) receptor antagonist and melatonin (MT1/MT2) receptor agonist with potential antidepressant-like activity in rodents

被引：11

作者：

Gao, Nana ^{[1
]}

Zheng, Wei ^{[2
]}

Murezati, Tiliwaerde ^{[2
]}

Gu, Wei ^{[3
]}

Li, Xiaorong ^{[2
]}

Jin, Zengliang ^{[2
]}

机构：

[1] Captial Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg & Clin Nutr, Beijing, Peoples R China

[2] Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100069, Peoples R China

[3] Beijing Guangwei Pharmaceut Technol Co Ltd, Beijing, Peoples R China

来源：

CNS NEUROSCIENCE & THERAPEUTICS | 2021年 / 27卷 / 06期

基金：

中国国家自然科学基金;

关键词：

5‐ HT2C receptor; antidepressant; GW117; melatonin receptor; REUPTAKE INHIBITORS; AGOMELATINE; NOREPINEPHRINE; DRUGS; MODEL; DEPRESSION; STRESS; RATS;

D O I：

10.1111/cns.13630

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Aims To evaluate the antidepressant-like effect of compound GW117 in rodents using in vitro binding and uptake assays as well in vivo behavioral tests. Methods We investigated the target profile of GW117 using [S-35]-GTP gamma S and [H-3]PIP binding. Using the forced swimming test and chronic unpredictable stress in rats, tail suspension test in mice and rats, and learned helplessness model in mice, we further revealed the antidepressant-like and anxiolytic-like effects of GW117. Results The current study suggests that GW117 displays serotonin 2C (5-HT2C) receptor antagonist and melatonin type 1 and 2 (MT1/MT2) receptor agonist properties, as well as evident antidepressant and anxiolytic effects. Conclusion These data suggest that GW117 is probably a potent antidepressant.

引用

页码：702 / 713

页数：12

共 50 条

[1] Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II) [J].

Ettaoussi, Mohamed ;

Peres, Basile ;

Errazani, Aicha ;

Boutin, Jean A. ;

Caignard, Daniel-Henri ;

Delagrange, Philippe ;

Melnyk, Patricia ;

Berthelot, Pascal ;

Yous, Said .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 90 :822-833

[2] Synthesis and Pharmacological Evaluation of a series of the Agomelatine Analogues as Melatonin MT1/MT2 Agonist and 5-HT2C Antagonist [J].

Ettaoussi, Mohamed ;

Sabaouni, Ahmed ;

Peres, Basile ;

Landagaray, Elodie ;

Nosjean, Olivier ;

Boutin, Jean A. ;

Caignard, Daniel-Henri ;

Delagrange, Philippe ;

Berthelot, Pascal ;

Yous, Said .

CHEMMEDCHEM, 2013, 8 (11) :1830-1845

[3] Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder [J].

Olie, Jean Pierre ;

Kasper, Siegfried .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05) :661-673

[4] Possibilities of preventive treatment of migraine with the MT1-and MT2 agonist and 5-HT2c receptor antagonist agomelatin (valdoxan) [J].

Tabeeva, G. R. ;

Sergeev, A. V. ;

Gromova, S. A. .

ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (09) :32-36

[5] Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents [J].

Rosenzweig-Lipson, Sharon ;

Sabb, Annmarie ;

Stack, Gary ;

Mitchell, Paul ;

Lucki, Irwin ;

Malberg, Jessica E. ;

Grauer, Steve ;

Brennan, Julie ;

Cryan, John F. ;

Rizzo, Stacey J. Sukoff ;

Dunlop, John ;

Barrett, James E. ;

Marquis, Karen L. .

PSYCHOPHARMACOLOGY, 2007, 192 (02) :159-170

[6] Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents [J].

Sharon Rosenzweig-Lipson ;

Annmarie Sabb ;

Gary Stack ;

Paul Mitchell ;

Irwin Lucki ;

Jessica E. Malberg ;

Steve Grauer ;

Julie Brennan ;

John F. Cryan ;

Stacey J. Sukoff Rizzo ;

John Dunlop ;

James E. Barrett ;

Karen L. Marquis .

Psychopharmacology, 2007, 192 :159-170

[7] Recent advances in the development of melatonin MT1 and MT2 receptor agonists [J].

Mor, Marco ;

Rivara, Silvia ;

Pala, Daniele ;

Bedini, Annalida ;

Spadoni, Gilberto ;

Tarzia, Giorgio .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (08) :1059-1077

[8] Agomelatine, a MT1/MT2 melatonergic receptor agonist with serotonin 5-HT2C receptor antagonistic properties, suppresses Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages [J].

Hyeon, Jin-Yi ;

Choi, Eun-Young ;

Choe, So-Hui ;

Park, Hae Ryoun ;

Choi, Jeom-Il ;

Choi, In Soon ;

Kim, Sung-Jo .

ARCHIVES OF ORAL BIOLOGY, 2017, 82 :11-18

[9] The expression of MT1, and MT2 melatonin receptor mRNA in several rat tissues [J].

Sallinen, P ;

Saarela, S ;

Ilves, M ;

Vakkuri, I ;

Leppäluoto, J .

LIFE SCIENCES, 2005, 76 (10) :1123-1134

[10] New Quinoxaline Derivatives as Potential MT1 and MT2 Receptor Ligands [J].

Ancizu, Saioa ;

Castrillo, Nerea ;

Perez-Silanes, Silvia ;

Aldana, Ignacio ;

Monge, Antonio ;

Delagrange, Philippe ;

Caignard, Daniel-Henry ;

Galiano, Silvia .

MOLECULES, 2012, 17 (07) :7737-7757

← 1 2 3 4 5 →